ライフサイエンスコーパス: thrombectomy

1 an important amount of futile transfers for thrombectomy.

2 in determining the benefits of transfer for thrombectomy.

3 rge vessel occlusion target for endovascular thrombectomy.

4 7 patients received local urokinase without thrombectomy.

5 improvement among patients receiving stroke thrombectomy.

6 scious sedation group (n = 77) during stroke thrombectomy.

7 potential benefits observed with aspiration thrombectomy.

8 nterior circulation who underwent mechanical thrombectomy.

9 ction in all-cause mortality with mechanical thrombectomy.

10 < 0.0001) were both improved with aspiration thrombectomy.

11 ) were significantly reduced with aspiration thrombectomy.

12 ntracoronary abciximab and manual aspiration thrombectomy.

13 rct lesion site but not by manual aspiration thrombectomy.

14 and to manual aspiration thrombectomy vs no thrombectomy.

15 s at baseline, after embolization, and after thrombectomy.

16 d at baseline, after embolization, and after thrombectomy.

17 al thrombolysis, and percutaneous mechanical thrombectomy.

18 e cerebral reperfusion prior to endovascular thrombectomy.

19 and who were not undergoing thrombolysis or thrombectomy.

20 h LVO, with or without additional mechanical thrombectomy.

21 that should predict favorable outcomes with thrombectomy.

22 val [CI], 1.41 to 3.69; P = 0.001), favoring thrombectomy.

23 = 150) given as a bolus before endovascular thrombectomy.

24 r intravenous thrombolysis and/or mechanical thrombectomy.

25 t retriever as first-line therapy for stroke thrombectomy.

26 d with sICH in patients receiving mechanical thrombectomy.

27 ion first pass or stent retriever first line thrombectomy.

28 (sICH) in patients who underwent mechanical thrombectomy.

29 ty-reducing interventions such as mechanical thrombectomy.

30 ays compared with stent retriever first line thrombectomy.

31 tionised by evidence of the effectiveness of thrombectomy.

32 mic core as applied in late time windows for thrombectomy.

33 ht assist patient selection for endovascular thrombectomy.

34 er (n = 189) immediately prior to mechanical thrombectomy.

35 to the infarct volume may benefit from late thrombectomy.

36 perative portal vein and/or 5 hepatic artery thrombectomies.

37 of angioplasty (0.28 versus 0.57 per year), thrombectomy (1.58 versus 0.94 per year), surgical revis

38 physiological group; n = 149), 123 underwent thrombectomies, 16 received interpositional vein grafts,

39 nts with acute ischaemic stroke who received thrombectomy, 19 had sICH (3.3%).

40 1287 patients (634 assigned to endovascular thrombectomy, 653 assigned to control).

41 iration (18 trials, n = 3,936) or mechanical thrombectomy (7 trials, n = 1,598) before PCI compared w

42 loon guide catheter was achieved in 89.2% of thrombectomies (91 of 102) versus 67.9% (55 of 81) achie

43 ion by diffusion weighted MRI, who underwent thrombectomy after meeting institutional criteria from J

44 s have shown possible benefits of mechanical thrombectomy after usual care compared with usual care a

45 d randomized trials that compared mechanical thrombectomy after usual care versus usual care alone fo

46 ke due to large artery occlusion, mechanical thrombectomy after usual care was associated with improv

47 tudy systematically determined if mechanical thrombectomy after usual care would be associated with b

48 ), including 1313 who underwent endovascular thrombectomy and 1110 who received standard medical care

49 y population comprised 10,064 patients (5035 thrombectomy and 5029 PCI alone).

50 e trials, 871 were allocated to endovascular thrombectomy and 893 were assigned standard care.

51 Mechanical thrombectomy and atherectomy are efficient methods of ar

52 ere was no difference between the mechanical thrombectomy and conventional primary PCI arms in the in

53 The use of thrombectomy and distal embolization protection devices

54 Until recently, randomized trials of thrombectomy and distal protection devices during primar

55 e evidence to date on the role of mechanical thrombectomy and embolic protection in native coronary a

56 This allograft was salvaged by early thrombectomy and interposition grafting.

57 between CT angiography followed by immediate thrombectomy and no vascular imaging in 55-year-old pati

58 ndomized, controlled trials comparing manual thrombectomy and PCI alone in patients with ST-segment-e

59 All patients underwent endovascular thrombectomy and received alteplase in usual care when i

60 Yet, with the advent of endovascular thrombectomy and the ability to investigate patients in

61 endpoint of MO was not different between the thrombectomy and the standard PCI group with 2.0%LV (int

62 ures: Intra-arterial treatment by mechanical thrombectomy and/or IA thrombolysis.

63 eous angioplasty, branch embolization, graft thrombectomy, and repeat bypass for late aneurysmal chan

64 llowed thrombolysis, percutaneous mechanical thrombectomy, and stenting to be used in conjunction wit

65 frequently revealed in the manual aspiration thrombectomy arm (patients with number of quadrants abov

66 he median value 60% in the manual aspiration thrombectomy arm and 37% in the RT arm, P=0.039).

67 ignificantly increased the odds of receiving thrombectomy as compared to discordant profiles (aOR = 3

68 sion in the Solitaire with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute

69 of the involved ischemic territory prior to thrombectomy, assessed by consensus of 2 blinded neurora

70 less likely to derive clinical benefit from thrombectomy at arrival).

71 nough to make them ineligible for mechanical thrombectomy at arrival.

72 myocardial infarction patients to aspiration thrombectomy before PCI versus conventional PCI.

73 Aspiration thrombectomy before primary PCI is not associated with a

74 y clinical benefits observed with aspiration thrombectomy before primary percutaneous coronary interv

75 s with aspiration thrombectomy or mechanical thrombectomy before primary percutaneous coronary interv

76 WHERE NEXT?: Thrombectomy benefits patients across a range of ages an

77 as intra-arterial thrombolysis or mechanical thrombectomy can also be employed.

78 n after transfer from community hospitals to thrombectomy-capable centers would be valuable.

79 h large vessel occlusion is transferred to a thrombectomy-capable centre determines outcome.

80 ischemic stroke initially admitted to a non-thrombectomy-capable RH and transferred to our center fo

81 nsferred from a referring hospital (RH) to a thrombectomy-capable stroke center (TCSC), patients with

82 death or MACE between any of the aspiration thrombectomy catheter devices analyzed.

83 propensity-matched analysis of 5 aspiration thrombectomy catheter devices used during percutaneous c

84 .32% among the most commonly used aspiration thrombectomy catheter devices, with relative risks for d

85 tive safety surveillance study of aspiration thrombectomy catheters using data within the National Ca

86 otal occlusions; true-lumen reentry devices; thrombectomy catheters; and embolic protection devices.

87 ng good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo.

88 A direct aspiration as first pass thrombectomy conferred non-inferior functional outcome a

89 troke in the anterior circulation undergoing thrombectomy, conscious sedation vs general anesthesia d

90 regional ischemic core and late time window thrombectomy criteria at CT perfusion.

91 s trial is the largest randomized study of a thrombectomy device published to date and demonstrates t

92 The PE thrombectomy device was highly effective, facilitating r

93 aire with the standard, predicate mechanical thrombectomy device, the Merci Retrieval System.

94 vascular treatment with the use of available thrombectomy devices (intervention group).

95 The results indicate that modern thrombectomy devices achieve faster and more complete re

96 otational atherectomy, laser angioplasty, or thrombectomy devices have not shown convincing superiori

97 theter-based treatment from first-generation thrombectomy devices to the game-changing stent retrieve

98 ions of technology in the fields of imaging, thrombectomy devices, and emergency room workflow manage

99 mes than the previously available mechanical thrombectomy devices.

100 ollowed by MT) compared to direct mechanical thrombectomy (dMT) for AIS patients with large vessel oc

101 Thrombectomy during AMI by manual catheter aspiration, b

102 ere enrolled, including 79 who had undergone thrombectomy during an open-label roll-in period.

103 es that adjunctive treatment with aspiration thrombectomy during primary percutaneous coronary interv

104 ed substantial reperfusion with endovascular thrombectomy, each 1-hour delay to reperfusion was assoc

105 Endovascular thrombectomy (ET) for acute ischemic stroke is the curre

106 The Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) trial was a multicentre,

107 gue for the use of thrombolytics or catheter thrombectomy even for hemodynamically stable patients.

108 etely minimally invasive technique for tumor thrombectomy even when cross-clamping of the cava is req

109 ies used to select patients for endovascular thrombectomy (EVT) are noncontrast computed tomography (

110 s of pivotal trials showed that endovascular thrombectomy (EVT) was highly effective, prompting calls

111 troke in the anterior circulation undergoing thrombectomy, first-line thrombectomy with contact aspir

112 ients were enrolled and randomly assigned to thrombectomy followed by PCI (n=5372) or to PCI alone (n

113 General anesthesia during thrombectomy for acute ischemic stroke has been associat

114 mal management of sedation and airway during thrombectomy for acute ischemic stroke is controversial

115 5, and May 31, 2016, and received mechanical thrombectomy for acute ischemic stroke.

116 ber 31, 2011, and Solitaire Flow Restoration Thrombectomy for Acute Revascularization from January 1,

117 2011 and May 2016, who underwent mechanical thrombectomy for anterior circulation occlusions, with a

118 st year, six positive trials of endovascular thrombectomy for ischaemic stroke have provided level 1

119 e improves reperfusion prior to endovascular thrombectomy for ischemic stroke compared with alteplase

120 d that outcomes are improved with the use of thrombectomy for large-vessel occlusion.

121 T angiography for all patients and immediate thrombectomy for LVO after intravenous thrombolysis, and

122 luding intravenous thrombolysis, with rescue thrombectomy for patients with LVO and neurologic deteri

123 best medical management with possible rescue thrombectomy for patients with LVO had a slightly higher

124 e aimed to assess the safety and efficacy of thrombectomy for the treatment of stroke in a trial embe

125 shown an overwhelming benefit of mechanical thrombectomy for treating patients with stroke caused by

126 We analyzed coronary thrombectomies from 111 patients with ST-elevation acute

127 tely intracorporeal techniques for IVC tumor thrombectomy from incremental advancements in laparoscop

128 -related quality of life was superior in the thrombectomy group (mean EQ-5D utility index score, 0.46

129 ents had undergone randomization (111 to the thrombectomy group and 110 to the control group).

130 r minor neurologic deficit, was 35.1% in the thrombectomy group and 20.0% in the control group (diffe

131 age occurred in 51.4% of the patients in the thrombectomy group and 24.5% of those in the control gro

132 nificantly between the two groups (6% in the thrombectomy group and 3% in the control group, P=0.50),

133 ndergo PCI in each group (337 in the PCI and thrombectomy group and 331 in the PCI alone group), the

134 ents were enrolled; 107 were assigned to the thrombectomy group and 99 to the control group.

135 th within 1 year occurred in 179 (4%) of the thrombectomy group and in 192 (4%) of 5029 in the PCI al

136 ntracranial hemorrhage were 1.9% in both the thrombectomy group and the control group (P=1.00), and r

137 ional independence at 90 days was 49% in the thrombectomy group as compared with 13% in the control g

138 ified Rankin scale at 90 days was 5.5 in the thrombectomy group as compared with 3.4 in the control g

139 year, occurred in 60 patients (1.2%) in the thrombectomy group compared with 36 (0.7%) in the PCI al

140 occurred in 395 (8%) of 5035 patients in the thrombectomy group compared with 394 (8%) of 5029 in the

141 ortality was 23% (24 of 103 patients) in the thrombectomy group versus 24% (25 of 103 patients) in th

142 D utility index score, 0.46 [SD 0.38] in the thrombectomy group vs 0.33 [0.33] in the control group,

143 therapy with the Solitaire stent retriever (thrombectomy group) or medical therapy alone (control gr

144 standard care plus mechanical thrombectomy (thrombectomy group) or standard care alone (control grou

145 gned to thrombectomy plus standard care (the thrombectomy group) or to standard care alone (the contr

146 Surgical thrombectomy had previously been abandoned secondary to

147 ed that CT angiography followed by immediate thrombectomy had the lowest cost ($346 007) and highest

148 tients with known complete reperfusion after thrombectomy had the same baseline computed tomography p

149 General anaesthesia (GA) during endovascular thrombectomy has been associated with worse patient outc

150 Over the past 15 years, minimally invasive thrombectomy has been reported in 78 patients in the lit

151 iques and better patient selection, surgical thrombectomy has regained a therapeutic role in treating

152 should, in parallel, proceed to endovascular thrombectomy immediately rather than waiting for an asse

153 Endovascular thrombectomy improved functional outcome at 3 months bot

154 ute ischemic stroke and whether endovascular thrombectomy improves clinical outcomes in such patients

155 er studies have shown that the neurovascular thrombectomy improves outcomes at 90 days post stroke.

156 We evaluated mechanical thrombectomy in a derivation cohort of patients at a com

157 The clinical efficacy of thrombectomy in acute myocardial infarction (AMI) remain

158 sing the role of thrombolysis and mechanical thrombectomy in acute stroke management.

159 Aspiration thrombectomy in conjunction with PCI in NSTEMI with a th

160 serve as a selection criteria surrogate for thrombectomy in late time windows.

161 There are no trials assessing thrombectomy in non-ST-segment elevation myocardial infa

162 el trial, with blinded outcome assessment of thrombectomy in patients presenting within 8 h of verteb

163 erfusion that occurs with rapid endovascular thrombectomy in patients who had an acute ischaemic stro

164 th unfavorable imaging profile evolution for thrombectomy in patients with ischemic stroke initially

165 Mechanical thrombectomy in select patients with acute ischemic stro

166 Aspiration thrombectomy in ST-segment elevation myocardial infarcti

167 During mechanical thrombectomy in the anterior cerebral circulation, throm

168 We studied the safety and efficacy of thrombectomy in the public health system of Brazil.

169 cted fibrinolysis with or without mechanical thrombectomy is appropriate in those with iliofemoral ob

170 Endovascular thrombectomy is of benefit to most patients with acute i

171 Furthermore, thrombectomy is offered by only a few, usually distant,

172 clusion ischemic stroke in whom endovascular thrombectomy is planned.

173 ery through thrombolysis and/or endovascular thrombectomy is restricted to only a small proportion of

174 Endovascular thrombectomy led to significantly reduced disability at

175 Among all 1287 patients (endovascular thrombectomy + medical therapy [n = 634]; medical therap

176 stroke, earlier treatment with endovascular thrombectomy + medical therapy compared with medical the

177 before thrombectomy to 90 mmHg +/- 32 after thrombectomy, mixed venous oxygen saturation increased f

178 roups: A) not attempted or failed mechanical thrombectomy (MT) and B) successful MT.

179 Mechanical thrombectomy (MT) improves clinical outcomes in patients

180 e (BP) angiosuites are performing mechanical thrombectomy (MT) in acute ischemic stroke patients.

181 ntly considered success following mechanical thrombectomy (MT) in acute stroke but is undetermined wh

182 IVT and adjunctive intra-arterial mechanical thrombectomy (MT) in patients who had acute ischaemic st

183 Endovascular treatment with mechanical thrombectomy (MT) is beneficial for patients with acute

184 us thrombolysis (IVT) followed by mechanical thrombectomy (MT) is recommended to treat acute ischemic

185 rievers and/or contact aspiration mechanical thrombectomy (MT) under general anaesthesia (GA) or cons

186 troke (AIS) patients treated with mechanical thrombectomy (MT), combined with the poor response of pr

187 d the clinical impact of PO after mechanical thrombectomy (MT).

188 study randomized 440 patients to adjunctive thrombectomy (n = 221) compared with conventional PCI (n

189 ngioplasty (n=12), stent placement (n=1), or thrombectomy (n=1) during subsequent interventions resul

190 g endovascular thrombectomy under GA, versus thrombectomy not under GA (with or without sedation) ver

191 tly, the addition of endovascular mechanical thrombectomy of large artery occlusion has revolutionize

192 Stent retriever thrombectomy of large-vessel occlusion results in better

193 ed with the treatment effect of endovascular thrombectomy on functional outcome.

194 al sought to assess the effect of aspiration thrombectomy on microvascular injury in patients with NS

195 te data on clinical outcomes with aspiration thrombectomy or mechanical thrombectomy before primary p

196 ad residual thrombus after manual aspiration thrombectomy or RT.

197 d, before treatment with either endovascular thrombectomy or standard medical therapy, by CTP as rela

198 (P=0.011), with 55% of all repairs involving thrombectomy or surgical revision.

199 % CI = 0.65-3.10, I(2) = 0%) or endovascular thrombectomy (OR = 0.78, 95% CI = 0.35-1.74, I(2) = 0%)

200 minogen activator, intra-arterial mechanical thrombectomy, or both, patients were randomized to 1 of

201 Effect sizes favouring endovascular thrombectomy over control were present in several strata

202 mised trials showed efficacy of endovascular thrombectomy over standard medical care in patients with

203 modify the treatment benefit of endovascular thrombectomy over standard medical therapy for improved

204 d with likelihood of favorable outcome after thrombectomy, particularly if reperfusion is successful.

205 There were 132 eligible thrombectomy patients and 132 matched controls treated w

206 (relative cerebral blood flow [rCBF], <30%), thrombectomy patients had a smaller median 24-hour infar

207 mal threshold to define the ischemic core in thrombectomy patients was rCBF <20% (area under the curv

208 MT for AIS (Solitaire With the Intention for Thrombectomy performed from January 1, 2010, through Dec

209 of thrombosed veins, including open surgical thrombectomy, pharmacological thrombolysis, and percutan

210 Endovascular thrombectomy plus medical therapy vs medical therapy alo

211 Patients were randomly assigned to thrombectomy plus standard care (the thrombectomy group)

212 s for disability at 90 days were better with thrombectomy plus standard care than with standard care

213 atients with ischemic stroke transferred for thrombectomy, poor collateral blood flow and stroke clin

214 and May 31, 2017, that compared endovascular thrombectomy predominantly done with stent retrievers wi

215 controlled trials that compared endovascular thrombectomy (predominantly using stent retrievers) with

216 Thrombectomy prior to intervention may enhance the safet

217 We sought to determine whether routine thrombectomy prior to stent implantation in diseased sap

218 g positive data in support of intra-arterial thrombectomy procedures.

219 The one-pass thrombectomy rate with the balloon guide catheter was si

220 205 of 206 outcomes available at 12 months, thrombectomy reduced disability over the range of the mR

221 ATION: At 12 months follow-up, neurovascular thrombectomy reduced post-stroke disability and improved

222 Thrombectomy reduced the severity of disability over the

223 8 hours after symptom onset, stent retriever thrombectomy reduced the severity of post-stroke disabil

224 Endovascular thrombectomy reduces disability in a broad group of pati

225 reduced all-cause mortality with mechanical thrombectomy (RR: 0.86; 95% CI: 0.72 to 1.02; p = 0.09).

226 this work was to determine whether rheolytic thrombectomy (RT) as an adjunct to primary percutaneous

227 The rheolytic thrombectomy (RT) device has the potential for improved

228 test strategies to reduce sICH risk and make thrombectomy safer in patients with elevated TAG scores.

229 INTERPRETATION: Thrombectomy salvaged tissue with lower CBF, likely attr

230 Mechanical neuro-thrombectomy seems equally safe and effective on a singl

231 of intravenous thrombolysis and endovascular thrombectomy shown to reduce disability.

232 Thrombectomy specimens were analyzed in 3 patients and d

233 Alternative thrombectomy strategies, particularly a direct aspiratio

234 mpared with the CT angiography and immediate thrombectomy strategy was 0.39 QALY, which corresponds t

235 thout sedation) versus standard care (ie, no thrombectomy), stratified by the use of GA versus standa

236 to stroke severity, rates of IVT/mechanical thrombectomy, symptomatic intracranial hemorrhage (sICH)

237 The Rotarex transcutaneous mechanical thrombectomy system is an efficient method of treating o

238 The effect of endovascular thrombectomy that is performed more than 6 hours after t

239 In case of complete PVT and failure of thrombectomy, the RPA offers satisfactory long-term resu

240 nvolving the anterior circulation undergoing thrombectomy, the use of protocol-based general anesthes

241 tio to receive standard care plus mechanical thrombectomy (thrombectomy group) or standard care alone

242 Thrombectomy/thromboendovenectomy was employed in 75% of

243 e ischemic stroke in a trial design allowing thrombectomy, thrombolysis, or both.

244 iences of robotic nephrectomy with IVC tumor thrombectomy, thus far, demonstrate feasibility but requ

245 ressure increased from 52 mmHg +/- 24 before thrombectomy to 90 mmHg +/- 32 after thrombectomy, mixed

246 rest in the concept of adjunctive mechanical thrombectomy to improve outcomes in primary percutaneous

247 The number needed to treat with endovascular thrombectomy to reduce disability by at least one level

248 t of prognosis and might inform endovascular thrombectomy treatment decisions.

249 nce to randomly allocate patients to receive thrombectomy treatment with either Solitaire or Merci (1

250 portance: After the many positive results in thrombectomy trials in ischemic stroke of the anterior c

251 irculation occlusion undergoing endovascular thrombectomy under GA, versus thrombectomy not under GA

252 es in clinical practice including mechanical thrombectomy up to 24 h after the ischemic event, there

253 rge vessel occlusions (LVO) can benefit from thrombectomy up to 24 hours after onset.

254 ent studies have proven the effectiveness of thrombectomy up to 24 hours after stroke onset for patie

255 A decision was made to perform mechanical thrombectomy using a Rotarex system followed by a stent-

256 Those randomised to additional MT underwent thrombectomy using any Conformite Europeene (CE)-marked

257 myocardial infarction among patients in the Thrombectomy Versus PCI Alone (TOTAL) trial.

258 vestigator-initiated trial of routine manual thrombectomy versus percutaneous coronary intervention (

259 Patients randomized to aspiration thrombectomy vs no aspiration had no significant differe

260 ite vs no abciximab and to manual aspiration thrombectomy vs no thrombectomy.

261 stroke, endovascular therapy with mechanical thrombectomy vs standard medical care with tPA was assoc

262 ials of endovascular therapy with mechanical thrombectomy vs standard medical care, which includes th

263 Aspiration thrombectomy vs. conventional primary PCI (18 trials, n=

264 Mechanical thrombectomy vs. conventional primary PCI (7 trials, n =

265 Mechanical thrombectomy was applied to 30 patients, and 7 patients

266 Compared with usual care alone, mechanical thrombectomy was associated with a higher incidence of a

267 Aspiration thrombectomy was associated with a nonsignificant increa

268 red with standard medical care, endovascular thrombectomy was associated with significantly higher ra

269 n compared with conventional PCI, aspiration thrombectomy was not associated with a significant reduc

270 In most patients, thrombectomy was performed in addition to thrombolysis w

271 Manual aspiration thrombectomy was performed with a 6 F aspiration cathete

272 brachial artery angiography with subsequent thrombectomy was performed.

273 PRETATION: Worse outcomes after endovascular thrombectomy were associated with GA, after adjustment f

274 Patients who underwent thrombectomy were matched by age, clinical severity, occ

275 loss of equipoise after positive results for thrombectomy were reported from other similar trials.

276 th intravenous thrombolysis and endovascular thrombectomy, which both reduce disability but are time-

277 proximal anterior intracranial circulation, thrombectomy with a stent retriever within 6 hours after

278 culation undergoing thrombectomy, first-line thrombectomy with contact aspiration compared with stent

279 benefit of combining endovascular mechanical thrombectomy with IV-rtPA over IV-rtPA alone.

280 Endovascular thrombectomy with or without intravenous alteplase in ac

281 h of symptom onset to receive routine manual thrombectomy with PCI or PCI alone.

282 via], and TOTAL [Trial of Routine Aspiration Thrombectomy With PCI Versus PCI Alone in Patients With

283 The trial of routine aspiration ThrOmbecTomy with PCI versus PCI ALone in Patients with

284 etrospective study of patients who underwent thrombectomy with preprocedural CT angiography that help

285 Endovascular thrombectomy with second-generation devices is beneficia

286 s alteplase when eligible) and neurovascular thrombectomy with Solitaire FR or medical therapy alone.

287 Conclusion The effectiveness of mechanical thrombectomy with stent retrievers in acute ischemic str

288 chemic stroke either to undergo endovascular thrombectomy with the Solitaire FR (Flow Restoration) st

289 geable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as c

290 Thrombectomy with the stent retriever plus intravenous t

291 To evaluate the effectiveness of mechanical thrombectomy with the use of a stent retriever in acute

292 e (control group) or to undergo endovascular thrombectomy with the use of a stent retriever within 6

293 Thrombectomy with the use of a stent retriever, in addit

294 stent implantation with versus without prior thrombectomy with the X-SIZER device (ev3, Plymouth, Min

295 Thrombectomy with the X-SIZER device prior to stent impl

296 vival, however, were not improved by routine thrombectomy with this device.

297 th sequentially numbered sealed envelopes to thrombectomy with Trevo or Merci devices.

298 omly assigned to receive either endovascular thrombectomy within 12 h of symptom onset or standard ca

299 neurological deficits and were treatable by thrombectomy within 8 h of stroke symptom onset.

300 ral failure (DWF), induced during mechanical thrombectomy, would be associated with grave outcomes.